RJA
HCA icon

Ross\Johnson & Associates’s HCA Healthcare HCA Stock Holding History

Ross\Johnson & Associates’s Portfolio HCA Stock Details HCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$390 Buy
+1
New +$423 0.01% 161

Other funds holding HCA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Ross\Johnson & Associates's HCA Position: Q2 2026 in Review

Ross\Johnson & Associates opened a new position in HCA Healthcare (HCA) in Q2 2026: 1 share worth $390. The stake represents 0.01% of the portfolio and ranks #161 among its holdings.

1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Ross\Johnson & Associates held 1 share of HCA Healthcare worth $390 as of Q2 2026.
  • HCA Healthcare was a new Ross\Johnson & Associates position in Q2 2026.
  • HCA Healthcare made up 0.01% of Ross\Johnson & Associates's portfolio in Q2 2026, its #161 holding.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Ross\Johnson & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.